Digital Veeva Commercial Summit 2025: On Data harmonisation with Ale... At Veeva Commercial Summit in Madrid, we spoke with Alexander Ulrich, Global Head of System Integration & Data Ownership at Boehringer Ingelheim.
Digital Innovative Modalities: Insights from Frontiers Health 2025 Advances in digital technologies aren’t just improving existing healthcare pathways, they’re opening the way for brand new treatment modalities.
Oncology ESMO25: On radiopharmaceutical possibilities in oncology, wi... At ESMO 2025, pharmaphorum spoke with Dr Ebrahim Delpassand, CEO of RadioMedix.
Digital Future-Proofing Health Systems: Insights from Frontiers Heal... At Frontiers Health 2025, we caught up with Moredreck Chibi (World Health Organization) and Chrys Herrera (Merck KGaA).
Patients Where Patients Lead: Insights from Frontiers Health 2025 At Frontiers Health 2025, patient advocate Silvia Cerolini (Eyes on the Future) opened the conference by sharing her story.
Oncology ESMO25: On allosteric modulation in oncology, with Michael L... At ESMO 2025, pharmaphorum had the pleasure of speaking with Michael Lahn, Chief Medical Officer at iOnctura.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.